Bristol Myers Squibb (BMY) Revenue (2009 - 2026)
Bristol Myers Squibb (BMY) reported Revenue of $11.5 billion for Q1 2026, up 2.57% year-over-year from $11.2 billion in Q1 2025, and down 8.1% on a QoQ basis from $12.5 billion in Q4 2025.
Bristol Myers Squibb (BMY) has 18 years of Revenue data on file, last reported at $11.5 billion in Q1 2026.
- Quarterly Revenue rose 2.57% year-over-year to $11.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $48.5 billion (up 1.78% YoY) and the FY2025 annual result came in at $48.2 billion, changed 0.22% from the prior year.
- Revenue slipped to $11.5 billion in Q1 2026 per BMY's latest filing, from $12.5 billion in the prior quarter.
- Across five years, Revenue topped out at $12.5 billion in Q4 2025 and bottomed at $11.0 billion in Q3 2023.
- The 5-year median for Revenue is $11.6 billion (2022), against an average of $11.7 billion.
- The widest annual swing landed in 2024, when Revenue rose 8.69%; it then dropped 5.6% in 2025.
- Tracing BMY's Revenue over 5 years: stood at $11.4 billion in 2022, then rose by 0.62% to $11.5 billion in 2023, then rose by 7.54% to $12.3 billion in 2024, then climbed by 1.3% to $12.5 billion in 2025, then decreased by 8.1% to $11.5 billion in 2026.
- Per Business Quant, the three latest BMY Revenue figures stand at $11.5 billion (Q1 2026), $12.5 billion (Q4 2025), and $12.2 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 19.80 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 24.06 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 15.00 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 16.29 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 8.62 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 6.96 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 2.34 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 11.49 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.49 Bn |
| Dec 31, 2025 | 12.50 Bn |
| Sep 30, 2025 | 12.22 Bn |
| Jun 30, 2025 | 12.27 Bn |
| Mar 31, 2025 | 11.20 Bn |
| Dec 31, 2024 | 12.34 Bn |
| Sep 30, 2024 | 11.89 Bn |
| Jun 30, 2024 | 12.20 Bn |
| Mar 31, 2024 | 11.87 Bn |
| Dec 31, 2023 | 11.48 Bn |
| Sep 30, 2023 | 10.97 Bn |
| Jun 30, 2023 | 11.23 Bn |
| Mar 31, 2023 | 11.34 Bn |
| Dec 31, 2022 | 11.41 Bn |
| Sep 30, 2022 | 11.22 Bn |
| Jun 30, 2022 | 11.89 Bn |
| Mar 31, 2022 | 11.65 Bn |
| Dec 31, 2021 | 11.99 Bn |
| Sep 30, 2021 | 11.62 Bn |
| Jun 30, 2021 | 11.70 Bn |
| Mar 31, 2021 | 11.07 Bn |
| Dec 31, 2020 | 11.07 Bn |
| Sep 30, 2020 | 10.54 Bn |
| Jun 30, 2020 | 10.13 Bn |
| Mar 31, 2020 | 10.78 Bn |
| Dec 31, 2019 | 7.95 Bn |
| Sep 30, 2019 | 6.01 Bn |
| Jun 30, 2019 | 6.27 Bn |
| Mar 31, 2019 | 5.92 Bn |
| Dec 31, 2018 | 5.97 Bn |
| Sep 30, 2018 | 5.69 Bn |
| Jun 30, 2018 | 5.70 Bn |
| Mar 31, 2018 | 5.19 Bn |
| Dec 31, 2017 | 5.45 Bn |
| Sep 30, 2017 | 5.25 Bn |
| Jun 30, 2017 | 5.14 Bn |
| Mar 31, 2017 | 4.93 Bn |
| Dec 31, 2016 | 5.24 Bn |
| Sep 30, 2016 | 4.92 Bn |
| Jun 30, 2016 | 4.87 Bn |
| Mar 31, 2016 | 4.39 Bn |
| Dec 31, 2015 | 4.29 Bn |
| Sep 30, 2015 | 4.07 Bn |
| Jun 30, 2015 | 4.16 Bn |
| Mar 31, 2015 | 4.04 Bn |
| Dec 31, 2014 | 4.26 Bn |
| Sep 30, 2014 | 3.92 Bn |
| Jun 30, 2014 | 3.89 Bn |
| Mar 31, 2014 | 3.81 Bn |
| Dec 31, 2013 | 4.44 Bn |
| Sep 30, 2013 | 4.07 Bn |
| Jun 30, 2013 | 4.05 Bn |
| Mar 31, 2013 | 3.83 Bn |
| Dec 31, 2012 | 4.19 Bn |
| Sep 30, 2012 | 3.74 Bn |
| Jun 30, 2012 | 4.44 Bn |
| Mar 31, 2012 | 5.25 Bn |
| Dec 31, 2011 | 5.45 Bn |
| Sep 30, 2011 | 5.35 Bn |
| Jun 30, 2011 | 5.43 Bn |
| Mar 31, 2011 | 5.01 Bn |
| Dec 31, 2010 | 5.11 Bn |
| Sep 30, 2010 | 4.80 Bn |
| Jun 30, 2010 | 4.77 Bn |
| Mar 31, 2010 | 4.81 Bn |
| Dec 31, 2009 | 5.03 Bn |
| Sep 30, 2009 | 4.79 Bn |
| Jun 30, 2009 | 4.67 Bn |
| Mar 31, 2009 | 4.32 Bn |